TipRanks
CanAlaska Uranium Ltd (TSE:CVV)
:CVV
Want to see TSE:CVV full AI Analyst Report?

CanAlaska Uranium (CVV) AI Stock Analysis

64 Followers

Top Page

TSE:CVV

CanAlaska Uranium

(CVV)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - Gpt-5.6Sol)
Rating:43Neutral
Price Target:
C$0.24
▼(-39.75% Downside)
Action:Reiterated
Date:10/02/26
The score is driven primarily by weak financial performance (pre-revenue, widening losses, and elevated cash burn) and bearish technicals (price below key moving averages with negative MACD). A low-debt balance sheet provides some support, but negative earnings and no dividend reduce valuation attractiveness.
Positive Factors
Athabasca Basin Exposure
Exposure to the Athabasca Basin gives CanAlaska a durable geographic focus in an established uranium district. Concentrating exploration activity there may improve access to proven geological knowledge and support the long-term potential of its project portfolio.
Negative Factors
Pre-Revenue Losses
The absence of revenue means CanAlaska has not yet demonstrated a commercial operating model or recurring inflows from its uranium assets. Widening losses indicate that spending is increasing without operating scale, leaving profitability dependent on future exploration success.
Read all positive and negative factors
Positive Factors
Negative Factors
Athabasca Basin Exposure
Exposure to the Athabasca Basin gives CanAlaska a durable geographic focus in an established uranium district. Concentrating exploration activity there may improve access to proven geological knowledge and support the long-term potential of its project portfolio.
Read all positive factors

CanAlaska Uranium (CVV) vs. iShares MSCI Canada ETF (EWC)

CanAlaska Uranium Business Overview & Revenue Model

Company Description
CanAlaska Uranium Ltd. is an exploration-stage company primarily engaged in identifying and developing mineral properties. The firm actively searches for deposits of uranium, nickel, copper, gold, and diamonds. Its significant holdings include an ...

CanAlaska Uranium Financial Statement Overview

Summary
Overall financial performance is weak: the company is pre-revenue with widening net losses and materially negative free cash flow (increasing cash burn). The main offset is a relatively strong balance sheet with very low leverage and a growing equity base, which supports near-term financial resilience despite negative returns on equity.
Income Statement
12
Very Negative
Balance Sheet
68
Positive
Cash Flow
18
Very Negative
BreakdownTTMApr 2026Apr 2025Apr 2024Jul 2023Apr 2021
Income Statement
Total Revenue0.000.000.000.000.000.00
Gross Profit-176.00K-177.00K-183.00K-196.00K-168.00K-105.00K
EBITDA-19.07M-20.27M-10.27M-9.48M-9.06M-6.05M
Net Income-17.67M-20.50M-10.52M-8.04M-9.27M-6.18M
Balance Sheet
Total Assets31.33M34.73M23.10M15.90M15.39M16.19M
Cash, Cash Equivalents and Short-Term Investments29.41M32.86M21.25M14.10M13.05M14.97M
Total Debt547.00K578.00K685.00K761.00K846.00K305.00K
Total Liabilities3.50M3.94M2.73M1.86M3.31M2.11M
Stockholders Equity27.83M30.79M20.37M14.04M12.08M14.08M
Cash Flow
Free Cash Flow-19.17M-18.08M-13.58M-11.77M-12.86M-6.26M
Operating Cash Flow-19.13M-18.03M-13.56M-11.48M-12.48M-5.89M
Investing Cash Flow-22.57M-25.46M812.00K-815.00K-213.00K-127.00K
Financing Cash Flow26.68M28.06M20.90M12.11M10.17M12.98M

CanAlaska Uranium Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.40
Price Trends
50DMA
0.33
Negative
100DMA
0.37
Negative
200DMA
0.56
Negative
Market Momentum
MACD
-0.02
Negative
RSI
45.02
Neutral
STOCH
41.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CVV, the sentiment is Negative. The current price of 0.4 is above the 20-day moving average (MA) of 0.29, above the 50-day MA of 0.33, and below the 200-day MA of 0.56, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 45.02 is Neutral, neither overbought nor oversold. The STOCH value of 41.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CVV.

CanAlaska Uranium Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
44
Neutral
C$144.79M-16.40-7.44%――-91.98%
44
Neutral
C$37.87M-4.78-27.09%――65.99%
43
Neutral
C$63.06M-3.41-55.38%――-9.21%
43
Neutral
C$75.20M-21.66-3.40%――24.32%
43
Neutral
C$78.56M-118.33-1.58%――-1650.00%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CVV
CanAlaska Uranium
0.29
-0.67
-70.00%
TSE:CCCM
C3 Metals
0.60
-0.51
-45.95%
TSE:LAM
Laramide Resources
0.51
-0.14
-21.54%
TSE:SAG
Sterling Metals
0.74
-0.91
-55.15%
TSE:SYH
Skyharbour Resources
0.36
-0.01
-2.74%

CanAlaska Uranium Corporate Events

Business Operations and StrategyExecutive/Board Changes
CanAlaska Uranium Taps Veteran Explorer James Sykes to Drive Pike Zone Growth
Positive
Sep 21, 2026
CanAlaska Uranium has appointed James Sykes as Vice President of Exploration, tasking him with leading the technical team to expand the Pike Zone discovery and pursue new uranium targets across the company’s Athabasca Basin portfolio. Sykes ...
Business Operations and Strategy
CanAlaska Starts Focused Fall Drilling at Athabasca Key Extension Uranium Project
Positive
Sep 8, 2026
CanAlaska Uranium has launched its 2026 fall drill program at the 100%-owned Key Extension project in the southeastern Athabasca Basin, south of the Key Lake Mine and Mill. The campaign will use one diamond drill to complete an estimated six to te...
Business Operations and StrategyExecutive/Board Changes
CanAlaska Assays Extend Uranium Trend at West McArthur’s Pike Zone
Positive
Aug 17, 2026
CanAlaska Uranium reported geochemical assay results from its 2026 winter drill program at the West McArthur Project in the southeastern Athabasca Basin. Drilling stepped out 350 metres northeast and southwest of the Pike Zone and intersected stro...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2026